Vapeboss – A recent study analyzed data from the Population Assessment of Tobacco & Health (PATH) study, finding no association between the use of electronic nicotine delivery systems (ENDS) and an increased risk of cardiovascular disease.

The study, titled "Longitudinal associations between exclusive nicotine delivery systems and cigarettes and self-reported incident diagnosed cardiovascular disease among adults," analyzed waves 1-5 of the PATH Study (2013-2019). The research team looked for the incident risk of self-reported diagnosed heart attacks (280 cases) and strokes (186 cases) and a possible association with ENDS and cigarette use among adults aged 40 and older.

The collected data found that exclusive cigarette use increased the risk of heart attack and stroke, while exclusive ENDS use did not.

The researchers concluded, “Compared to non-use, exclusive cigarette use was associated with an increased risk of self-reported incident diagnosed cardiovascular disease over a five-year period, while ENDS use was not associated with a statistically significant increase in outcomes.”

Another recent study in the journal Nicotine and Tobacco Research highlighted the relative safety of smokeless tobacco products and how switching from cigarettes to these products was associated with a lower risk of heart disease in smokers.

The study, titled "Associations of Smokeless Tobacco Use With Cardiovascular Disease Risk: Insight From the Population Assessment of Tobacco and Health Study," was conducted by a research team from UCLA, UC San Francisco, Boston University, and the University of Texas at Arlington.

The researchers analyzed data from a nationally representative cohort of 4,347 adults who provided urine and blood samples in 2013–14 as part of the Population Assessment of Tobacco and Health (PATH) Study. Among this group, 3,034 participants exclusively used cigarettes, 338 exclusively used smokeless tobacco, and 975 never used any tobacco products.

The research team found that despite similar nicotine levels, smokeless tobacco users showed significantly lower disease biomarkers. “Our findings indicate that despite having higher nicotine levels, exclusive smokeless tobacco users had significantly lower concentrations of inflammatory and oxidative stress biomarkers than smokers. Biomarker levels among smokeless tobacco users were similar to those who never smoked,” said lead study author Mary Rezk-Hanna, an assistant professor at the UCLA School of Nursing.

Source: Vapingpost